Literature DB >> 33504498

Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus.

Sarah Derby1,2, Matthew Forshaw3, Caroline Lowrie4, Derek Grose4, Husam Marashi4, Philip McLoone5, Christina Wilson4, David McIntosh4.   

Abstract

BACKGROUND: Oesophageal cancer remains a common cause of cancer mortality worldwide. Increasingly, oncology centres are treating an older population and comorbidities may preclude multimodality treatment with chemoradiotherapy (CRT). We review outcomes of radical radiotherapy (RT) in an older population treating squamous cell carcinoma (SCC) oesophagus.
METHODS: Patients over 65 years receiving RT for SCC oesophagus between 2013 and 2016 in the West of Scotland were identified. Kaplan-Meier and Cox-regression analysis were used to compare overall survival (OS) between patients treated with radical RT and radical CRT.
RESULTS: There were 83 patients over 65 years treated with either RT (n=21) or CRT (n=62). There was no significant difference in median OS between CRT versus RT (26.8 months vs 28.5 months, p=0.92). All patients receiving RT completed their treatment whereas 11% of CRT patients did not complete treatment.
CONCLUSION: Survival in this non-trial older patient group managed with CRT is comparable to that reported in previous trials. RT shows better than expected outcomes which may reflect developments in RT technique. This review supports RT as an alternative in older patients, unfit for concurrent treatment. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  cancer; chemotherapy; oesophageal cancer; radiation therapy

Year:  2021        PMID: 33504498      PMCID: PMC7843319          DOI: 10.1136/bmjgast-2020-000492

Source DB:  PubMed          Journal:  BMJ Open Gastroenterol        ISSN: 2054-4774


  30 in total

1.  Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†.

Authors:  L Decoster; K Van Puyvelde; S Mohile; U Wedding; U Basso; G Colloca; S Rostoft; J Overcash; H Wildiers; C Steer; G Kimmick; R Kanesvaran; A Luciani; C Terret; A Hurria; C Kenis; R Audisio; M Extermann
Journal:  Ann Oncol       Date:  2014-06-16       Impact factor: 32.976

2.  Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015.

Authors:  C Castro; C Bosetti; M Malvezzi; P Bertuccio; F Levi; E Negri; C La Vecchia; N Lunet
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

3.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

4.  Experience of Definitive Chemoradiation for Oesophageal Cancer Within a Large Regional Cancer Treatment Centre: Improving Outcomes and Tolerability.

Authors:  V J Lavin; S Mehta; P Sumra; X Wang; L Bhatt; A S Jackson; H Y Sheikh
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-07-26       Impact factor: 4.126

5.  Sex-associated differences in presentation and survival in patients with lung cancer.

Authors:  M K Ferguson; C Skosey; P C Hoffman; H M Golomb
Journal:  J Clin Oncol       Date:  1990-08       Impact factor: 44.544

6.  Sex differences in lung cancer survival: do tumors behave differently in elderly women?

Authors:  Juan P Wisnivesky; Ethan A Halm
Journal:  J Clin Oncol       Date:  2007-05-01       Impact factor: 44.544

7.  Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.

Authors:  R W Byhardt; C Scott; W T Sause; B Emami; R Komaki; B Fisher; J S Lee; C Lawton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-10-01       Impact factor: 7.038

8.  SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus.

Authors:  Christopher N Hurt; Lisette S Nixon; Gareth O Griffiths; Ruby Al-Mokhtar; Simon Gollins; John N Staffurth; Ceri J Phillips; Jane M Blazeby; Tom D Crosby
Journal:  BMC Cancer       Date:  2011-10-28       Impact factor: 4.430

9.  Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009.

Authors:  Kyu-Won Jung; Sohee Park; Aesun Shin; Chang-Mo Oh; Hyun-Joo Kong; Jae Kwan Jun; Young-Joo Won
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 10.  Use of geriatric assessment for older adults in the oncology setting: a systematic review.

Authors:  M T E Puts; J Hardt; J Monette; V Girre; E Springall; S M H Alibhai
Journal:  J Natl Cancer Inst       Date:  2012-07-31       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.